FDA’s Abbreviated New Drug Application Process Explained: How Generic Drugs Get Approved
The FDA's Abbreviated New Drug Application (ANDA) process lets generic drug makers prove their products are equivalent to brand-name drugs without repeating costly clinical trials. This system saves Americans $373 billion annually and makes 90% of prescriptions affordable.
